Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_assertion type Assertion NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_head.
- NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_assertion description "[The United States CF Foundation recently proposed the term cystic fibrosis transmembrane conductance regulator related metabolic syndrome (CRMS) to describe infants with elevated immunoreactive trypsinogen (IRT) on NBS who do not meet diagnostic criteria for CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_provenance.
- NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_assertion evidence source_evidence_literature NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_provenance.
- NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_assertion SIO_000772 21538969 NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_provenance.
- NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_assertion wasDerivedFrom befree-20140225 NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_provenance.
- NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_assertion wasGeneratedBy ECO_0000203 NP862170.RAJKOZhV8Pmn582kP1wqGoMwpvdrV4T8ekt7vCjC89XMM130_provenance.